147 related articles for article (PubMed ID: 9609125)
41. Beta-cell ontogeny: growth and death.
Corbett J; Serup P; Bonner-Weir S; Nielsen JH
Diabetologia; 1997 Oct; 40 Suppl 3():B27-32. PubMed ID: 9345642
[No Abstract] [Full Text] [Related]
42. Insulin receptor knock-out mice.
Accili D
Trends Endocrinol Metab; 1997 Apr; 8(3):101-4. PubMed ID: 18406794
[TBL] [Abstract][Full Text] [Related]
43. On the function of insulin: a general theory.
JACOBS HR
Q Bull Northwest Univ Med Sch; 1947; 21(4):329-34. PubMed ID: 20271390
[No Abstract] [Full Text] [Related]
44. Genetic engineering in mice: impact on insulin signalling and action.
Lamothe B; Baudry A; Desbois P; Lamotte L; Bucchini D; De Meyts P; Joshi RL
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):193-204. PubMed ID: 9761714
[TBL] [Abstract][Full Text] [Related]
45. Genetic manipulation of insulin action and beta-cell function in mice.
Lamothe B; Duvillié B; Cordonnier N; Baudry A; Saint-Just S; Bucchini D; Jami J; Joshi RL
Mol Cell Biochem; 1998 May; 182(1-2):161-8. PubMed ID: 9609125
[TBL] [Abstract][Full Text] [Related]
46. Genetically engineered mice as animal models for NIDDM.
Joshi RL; Lamothe B; Bucchini D; Jami J
FEBS Lett; 1997 Jan; 401(2-3):99-103. PubMed ID: 9013866
[TBL] [Abstract][Full Text] [Related]
47. Genetic manipulation of insulin signaling, action and secretion in mice. Insights into glucose homeostasis and pathogenesis of type 2 diabetes.
Baudry A; Leroux L; Jackerott M; Joshi RL
EMBO Rep; 2002 Apr; 3(4):323-8. PubMed ID: 11943762
[TBL] [Abstract][Full Text] [Related]
48. Unlocking the secrets of the pancreatic beta cell: man and mouse provide the key.
Hattersley AT
J Clin Invest; 2004 Aug; 114(3):314-6. PubMed ID: 15286795
[TBL] [Abstract][Full Text] [Related]
49. Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus: what can we learn from transgenic and knockout mice?
Mauvais-Jarvis F; Kahn CR
Diabetes Metab; 2000 Dec; 26(6):433-48. PubMed ID: 11173714
[TBL] [Abstract][Full Text] [Related]
50. Tissue-specific targeting of the insulin receptor gene.
Kulkarni RN; Okada T
Endocrine; 2002 Dec; 19(3):257-66. PubMed ID: 12624425
[TBL] [Abstract][Full Text] [Related]
51. Increased glycogen accumulation in transgenic mice overexpressing glycogen synthase in skeletal muscle.
Manchester J; Skurat AV; Roach P; Hauschka SD; Lawrence JC
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10707-11. PubMed ID: 8855244
[TBL] [Abstract][Full Text] [Related]
52. Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A.
Cummings DE; Brandon EP; Planas JV; Motamed K; Idzerda RL; McKnight GS
Nature; 1996 Aug; 382(6592):622-6. PubMed ID: 8757131
[TBL] [Abstract][Full Text] [Related]
53. Candidate genes for insulin resistance.
Moller DE; Bjørbaek C; Vidal-Puig A
Diabetes Care; 1996 Apr; 19(4):396-400. PubMed ID: 8729172
[TBL] [Abstract][Full Text] [Related]
54. Correction of diabetic alterations by glucokinase.
Ferre T; Pujol A; Riu E; Bosch F; Valera A
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7225-30. PubMed ID: 8692973
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
